ArticleScientific reports2026
Life expectancy after kidney transplantation in a population-based retrospective cohort.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The mediating role of self-efficacy in the association between social support and eHealth literacy among kidney transplant recipients.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kidney transplantation is the treatment of choice for end-stage renal disease, offering significant survival benefits. However, outcomes vary based on donor type and patient characteristics. We aimed to identify factors influencing long-term survival following kidney transplantation. This was a population-based retrospective cohort study of kidney transplant recipients from 2005 to 2018 in Israel, assessing survival from one-month post-transplant. Univariate and multivariate Cox regression analyses were performed to identify predictors of mortality. Among 1,847 recipients, 679 received kidneys from living donors and 1,168 from deceased donors. The median age was 52 years (IQR 38–62), and the mean post-transplant survival time was 11.9 years (95% CI 11.7–12.3). Increased mortality risk was associated with age over 65 years (HR 3.73), current or past smoking (HR= 1.32), diabetes mellitus (HR= 1.79), heart failure (HR= 1.49), and atrial fibrillation (HR= 1.79). Receiving a kidney from a living donor (HR= 0.49) and higher pre-transplant hemoglobin levels (HR= 0.75) were linked to improved survival. Recipient comorbidities and donor type are key determinants of post-transplant outcomes. These findings support a tailored approach to transplant evaluation, balancing potential survival and quality-of-life benefits with individual risk profiles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.